AJMC October 2, 2022
Skylar Jeremias

Gene therapy can be used to treat retinitis pigmentosa, an inherited eye disease, and there is likely to be an increase in approved gene therapies for ophthalmic conditions, explained Michel Michaelides, MD, FACP, a consultant ophthalmologist and a professor of ophthalmology at the University College London Institute of Ophthalmology’s Genetics Department.

Michel Michaelides, MD, FACP, explains how gene therapy can be used to treat retinitis pigmentosa, an inherited eye disease, and how it could be used in the future of eye care. Michaelides is a consultant ophthalmologist at Moorfields Eye Hospital in the Department of Medical Retina, Inherited Eye Disease and Paediatric Ophthalmology and a professor of ophthalmology at the University College London Institute of Ophthalmology’s Genetics Department.

Transcript

What...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Conferences / Podcast, Pharma / Biotech, Trends
World Immunization Week 2024: mRNA vaccines hold potential in multiple disease areas
Moderna turns to AI to change how its employees work
AI-enabled drug discovery company Xaira launches with $1B
A new kind of gene-edited pig kidney was just transplanted into a person
25 most expensive hospital drugs

Share This Article